Alpine Woods Capital Investors’s Alpine Immune Sciences Inc ALPN Stock Holding History

Alpine Woods Capital Investors’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,580	Closed	-$30K	–	274
2020 Q1	$30K	Hold	10,580	–	–	0.01%	256
2019 Q4	$41K	Sell	10,580 -4,420	-29%	-$13.8K	0.01%	254
2019 Q3	$59K	Hold	15,000	–	–	0.01%	261
2019 Q2	$63K	Hold	15,000	–	–	0.01%	271
2019 Q1	$103K	Hold	15,000	–	–	0.02%	252
2018 Q4	$55K	Hold	15,000	–	–	0.01%	272
2018 Q3	$95K	Hold	15,000	–	–	0.02%	246
2018 Q2	$114K	Buy	15,000 +5,000	+50%	+$41.2K	0.02%	238
2018 Q1	$80K	Hold	10,000	–	–	﹤0.01%	389
2017 Q4	$112K	Buy	+10,000	New	+$109K	0.01%	434

Other funds holding ALPN

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCA

Berman Capital Advisors Atlanta, Georgia $636M AUM 30.04% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpine Woods Capital Investors's ALPN Position: Q2 2020 in Review

Alpine Woods Capital Investors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2020, closing a stake of 10,580 shares — an estimated $30K sold.

Alpine Woods Capital Investors first reported a position in ALPN in Q4 2017 and held it in 10 quarters. The position peaked at $114K in Q2 2018. 22 funds tracked by Wall St. Rank hold ALPN as of Q2 2020.

Alpine Woods Capital Investors reported no remaining Alpine Immune Sciences Inc position as of Q2 2020 after selling out during the quarter.
Alpine Woods Capital Investors sold 10,580 Alpine Immune Sciences Inc shares in Q2 2020, an estimated $30K.
Alpine Woods Capital Investors first reported a position in Alpine Immune Sciences Inc in Q4 2017 and held it in 10 quarters.
Alpine Woods Capital Investors's Alpine Immune Sciences Inc position peaked at $114K in Q2 2018.
22 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2020.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2020, filed 10 Aug 2020.